Therapeutic Asset Ratings
603 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
19-28z/il-18 car t cells
Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
19-28z/il-18 car t cells
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
19-28z/il-18 car t cells
Adult Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
ALECTINIB
Anaplastic Lymphoma Kinase
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Avutometinib
CNS Tumor, Adult
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Avutometinib
Central Nervous System Neoplasm
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Avutometinib
Low Grade Glioma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Avutometinib
MAP Kinase Family Gene Mutation
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Avutometinib
Neurofibromatosis Type 1
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Avutometinib
Optic Pathway Glioma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Avutometinib
Plexiform Neurofibroma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Avutometinib
Primary Brain Neoplasm
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
azd1390
Metastatic Neoplasm
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
BMS-986345
Anaplastic Lymphoma Kinase
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
BMS-986345
NK-Cell Lymphomas
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
BMS-986345
T-cell Large Granular Lymphocyte Leukemia
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
BMS-986504
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
cd371-specific/ysnvz/i-18 car t cells
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Ciml-Nk Cell Therapy
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Cyclophosphamide
Adnexal Carcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Cyclophosphamide
Basal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Cyclophosphamide
BCC - Basal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Cyclophosphamide
Extramammary Paget Disease
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Cyclophosphamide
Sebaceous Carcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Cytosin-Arabinosid
Secondary Central Nervous System Lymphoma (SCNSL)
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Showing 376 to 400 of 603 assets
Previous
Page 16 of 25
Next
